UPSTREAM BIO INC. - C

Upstream Bio Appoints Stacy Price as Chief Technology Officer

20 May 2025 04:00:00 By Nasdaq GlobeNewswire

Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs

06 May 2025 04:00:00 By Nasdaq GlobeNewswire

Upstream Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

12 Mar 2025 04:00:00 By Nasdaq GlobeNewswire

Upstream Bio to Present at Upcoming March Investor Conferences

25 Feb 2025 05:00:01 By Nasdaq GlobeNewswire

Upstream Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference

06 Jan 2025 05:00:01 By Nasdaq GlobeNewswire

Upstream Bio Appoints Allison Ambrose as General Counsel

17 Dec 2024 05:00:00 By Nasdaq GlobeNewswire

Upstream Bio Announces Addition to Russell 2000® Index

16 Dec 2024 05:00:04 By Nasdaq GlobeNewswire

Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference

21 Nov 2024 05:00:00 By Nasdaq GlobeNewswire

Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights

07 Nov 2024 04:00:01 By Nasdaq GlobeNewswire

Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

15 Oct 2024 13:15:00 By Nasdaq GlobeNewswire